Belpointe Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Belpointe Asset Management's NVO Position: Q1 2026 in Review
Belpointe Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 21,951 shares — an estimated $1.12M sold.
Belpointe Asset Management first reported a position in NVO in Q2 2021 and held it in 17 quarters. The position peaked at $1.35M in Q3 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Belpointe Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Belpointe Asset Management sold 21,951 Novo Nordisk shares in Q1 2026, an estimated $1.12M.
- Belpointe Asset Management first reported a position in Novo Nordisk in Q2 2021 and held it in 17 quarters.
- Belpointe Asset Management's Novo Nordisk position peaked at $1.35M in Q3 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.